Comparative effects of fixed ‐dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial

ConclusionsIn our short-duration randomized crossover study, although not impacting vascular endothelial function, mitiglinide/voglibose demonstrated potential benefits in reducing glycemic variability, postprandial hyperglycemia, and hypoglycemia in patients with type 2 diabetes.

https://onlinelibrary.wiley.com/doi/10.1111/jdi.14138?af=R

Source: Journal of Diabetes Investigation - December 27, 2023 Category: Endocrinology Authors: Kenichi Tanaka, Yosuke Okada, Saeko Umezu, Ryoma Hashimoto, Yukiko Tomoyose, Rina Tateyama, Yuri Hori, Momo Saito, Akemi Tokutsu, Satomi Sonoda, Fumi Uemura, Akira Kurozumi, Yoshiya Tanaka Tags: Clinical Trial Source Type: research